Thank you, Mr. Chair.
I'd also like to thank all of the witnesses for joining today and for their great testimony up to this point.
I want to continue with Mr. Scongack.
You talked quite effusively about some of the economic opportunities with medical isotopes, among other things. I wonder if you could expand on whether you have a sense of what that economic opportunity is overall and how that translates between companies and the public, particularly in Canada right now.